A limited-edition of 50 examples, the Czapek × Fratello Promenade Transparencies “Viridian Green” retails for €32,000 EUR (approx. $33,727 USD) and is currently available for pre-order via ...

Earnings season is upon us again, and most public cannabis companies will release results for the 4th quarter of 2022 in the next few weeks. Only two of the companies in the graph have reported to ...

Located within a 2,000-acre master-planned community, the luxury project will have a mix of apartments and townhomes.

StreetLights Residential has broken ground on the third and final phase of its multifamily development in Arlington’s ...

Viridian Therapeutics has a couple of milestones upcoming in 2025 and more pivotal once scheduled in 2026. Click here to find out why VRDN stock is a Buy.

Viridian's thyroid eye disease drug veligrotug clears its first phase 3 trial, with data suggesting it could be competitive with Amgen's Tepezza.

Viridian draws an ethnically diverse crowd, but the clientele does skew young (20s and 30s), and it especially skews toward the demographic I’ve always referred to as the Cool Asian, in every single ...